The Expert Panel of Enzymes, International Federation of Clinical Chemistry has published its recommendations for the measurement of serum AST. The Synermed® method for measuring AST activity in serum is based upon these recommendations.
The aspartate aminotransferase in the sample catalyzes the transfer of the amino group from aspartate to alpha-ketoglutarate to form oxalacetate and glutamate.
AST
L-aspartate + α-ketoglutarate -> oxalacetate + glutamate
The oxalacetate is reduced to malate in the presence of malate dehydrogenase (MDH) with the concurrent oxidation of reduced nicotinamide adenine dinucleotide (NADH) to nicotinamide adenine dinucleotide [NAD].
MDH
oxalacetate + NADH -> malate + NAD
The resulting rate of decrease in absorbance at 340 nm is directly proportional to the AST activity in the sample. The enzyme lactate dehydrogenase [LDH] is included in the reagent to prevent interference from endogenous alpha-keto acids normally found in human serum.
Cat No. | Product Name | Packaging | Package Volume (mL) | Storage |
UV085-X | AST/GOT | 1x100 mL + 1x25 mL | 125 | 0-4° C |
UV085 | AST/GOT | 4x100 mL + 1x100 mL | 500 | 0-4° C |
UV082-L | AST/GOT Starter | 6x500 mL | 3,000 | 0-4° C |
UV084-L | AST/GOT Enzyme Substrate | 6x500 mL | 3,000 | 0-4° C |
UV085-911 | AST/GOT | 4x50 mL + 1x50 mL | 150 | 0-4° C |
UV085-WK | AST/GOT | 4x25mL + 4x6.25mL | 125 | 0-4° C |